Long-term safety and tolerability of paliperidone palmitate in patients with schizophrenia

被引：0
|
作者：
Gopal, S. [1 ]
Vijapurkar, U. [1 ]
Lim, P. [1 ]
Morozova, M. [2 ]
Eerdekens, M. [3 ]
Hough, D. [1 ]
机构：
[1] Johnson & Johnson, Skillman, NJ USA
[2] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 109801, Russia
[3] Johnson & Johnson, Beerse, Belgium
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：218 / 219
页数：2
相关论文
共 50 条
  • [1] Long-term safety, tolerability and pharmacokinetics of paliperidone palmitate : A one-year open-label study in patients with schizophrenia
    Gopal, S.
    Coppola, D.
    Liu, Y.
    Remmerie, B.
    Samtani, M.
    Pandina, G.
    Hough, D.
    Nuamah, I.
    Sulaiman, A. H.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 219 - 219
  • [2] LONG-TERM SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PALIPERIDONE PALMITATE: A ONE-YEAR OPEN-LABEL STUDY IN PATIENTS WITH SCHIZOPHRENIA.
    Coppola, D.
    Liu, Y.
    Gopal, S.
    Remmerie, B.
    Samtani, M.
    Pandina, G.
    Hough, D.
    Nuamah, I.
    Sulaiman, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S25 - S25
  • [3] Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia
    Hough, David
    Lindenmayer, Jean-Pierre
    Gopal, Srihari
    Melkote, Rama
    Lim, Pilar
    Herben, Virginie
    Yuen, Eric
    Eerdekens, Marielle
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (06): : 1022 - 1031
  • [4] Paliperidone palmitate in short- and long-term treatment of schizophrenia
    Valsecchi, Paolo
    Barlati, Stefano
    Garozzo, Andrea
    Deste, Giacomo
    Nibbio, Gabriele
    Turrina, Cesare
    Sacchetti, Emilio
    Vita, Antonio
    [J]. RIVISTA DI PSICHIATRIA, 2019, 54 (06) : 235 - 248
  • [5] PALIPERIDONE PALMITATE INJECTION: ITS EFFICACY, SAFETY AND TOLERABILITY IN SCHIZOPHRENIA
    Owen, R. T.
    [J]. DRUGS OF TODAY, 2010, 46 (07) : 463 - 471
  • [6] Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
    Sliwa, Jennifer Kern
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Turkoz, Ibrahim
    Alphs, Larry
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 375 - 385
  • [7] LONG-TERM SAFETY AND TOLERABILITY OF BREXPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA
    Hakala, Mika
    Gislum, Mette
    Skuban, Aleksandar
    Meehan, Stine
    [J]. SCHIZOPHRENIA BULLETIN, 2018, 44 : S94 - S95
  • [8] Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia
    Si, Tianmei
    Zhuo, Jianmin
    Feng, Yu
    Lu, Huafei
    Hong, Di
    Zhang, Lili
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 1685 - 1694
  • [9] Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
    Nasrallah, Henry A.
    Aquila, Ralph
    Du, Yangchun
    Stanford, Arielle D.
    Claxton, Amy
    Weiden, Peter J.
    [J]. CNS SPECTRUMS, 2019, 24 (04) : 395 - 403
  • [10] Safety and tolerability of the investigational antipsychotic paliperidone palmitate injected in the deltoid or gluteus muscle in patients with schizophrenia
    Gopal, Srihari
    Lindenmayer, Jean-Pierre
    Hough, David
    Melkote, Rama
    Lim, Pilar
    Eerdekens, Marielle
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 285S - 285S
12345